AXA/2025/FY/Earnings presentation: Difference between revisions
Content deleted Content added
PlumBot: publish from draft |
PlumBot: publish from draft |
||
Line 19:
=== Full Year 2025 earnings presentation ===
*
* February 26, 2026 <sup>p. 1</sup>
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
* Certain statements are forward-looking, including predictions of future events, trends, plans, expectations, or objectives, and are identified by words like 'expects', 'anticipates', 'may', 'plan,' 'target' or conditional verbs such as 'would' and 'could' <sup>p. 2</sup>.
* Statements regarding expected '''underlying earnings per share''' ('UEPS') growth for 2026 are forward-looking statements providing one-off guidance for the last year of the Group's current strategic plan <sup>p. 2</sup>.
* These statements are based on Management's current views and intentions and are subject to change <sup>p. 2</sup>.
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties, many outside AXA's control, which could cause actual results to differ materially <sup>p. 2</sup>.
* Each forward-looking statement speaks only at the date of this presentation <sup>p. 2</sup>.
* Refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 (the '2024 Universal Registration Document') for a description of important factors, risks, and uncertainties <sup>p. 2</sup>.
* AXA disclaims any obligation to publicly update or revise any forward-looking statements, except as required by applicable laws and regulations <sup>p. 2</sup>.
*
*
* None of these non-GAAP financial measures should be considered in isolation from, or as a substitute for, the Group's consolidated financial statements and related notes prepared in accordance with IFRS <sup>p. 2</sup>.
* '''Underlying earnings''', UEPS ('underlying earnings per share'), '''underlying return on equity''', '''combined ratio''', and '''debt gearing''' are APMs as defined in ESMA's guidelines and the AMF's related position statement issued in 2015 <sup>p. 2</sup>.
* AXA provides a reconciliation of such APMs to the most closely related line item, subtotal, or total in the financial statements of the corresponding period (and/or their calculation methodology) in its Activity Report as of December 31, 2025 ('AXA's 2025 Activity Report'), under the heading 'Use of non-GAAP and alternative performance measures' <sup>p. 2</sup>.
* For further information on non-GAAP financial measures, see the Glossary in AXA's 2025 Activity Report <sup>p. 2</sup>.
* AXA's Activity Report as of December 31, 2025 is available on the AXA Group website (www.axa.com) <sup>p. 2</sup>.
* AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA's statutory auditors <sup>p. 2</sup>.
=== Table of contents ===
* '''1. FY25 Highlights''': presented by Thomas Buberl, Group CEO, starting on page 04 <sup>p. 3</sup>.
* '''2. FY25 Business Performance''': presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology, starting on page 09 <sup>p. 3</sup>.
* '''3. FY25 Financial Performance''': presented by Alban de Mailly Nesle, Group CFO, starting on page 13 <sup>p. 3</sup>.
== FY25 Highlights ==
Line 48 ⟶ 50:
=== 1 FY25 Highlights ===
*
* Thomas Buberl, Group CEO <sup>p. 4</sup>
=== Full Year 2025 | Excellent performance ===
* '''Revenues''' +6% vs. FY24 <sup>p. 5</sup>
* '''Underlying EPS''' +8% vs. FY24 <sup>p. 5</sup>
* '''ROE'''
* '''Solvency II ratio'''
* Delivering value for shareholders with
**
** The annual share
* Confident to deliver '''underlying EPS growth''' at the upper end of 6%-8% target range for 2026 <sup>p. 5</sup>.
=== Executing the plan on growth, margin and efficiency ===
<div style="overflow-x:auto">
{| class="wikitable"
! style="text-align:left" | Metric
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying earnings
| class="col-s" style="text-align:right" | EUR 8.1bn
| class="col-s" style="text-align:right" | EUR 8.4bn
| class="col-s" style="text-align:right" | +6% overall, +9% excluding AXA IM
|-
| style="text-align:left" | Top line growth
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | +6%
|-
| style="text-align:left" | P&C
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | +5%
|-
| style="text-align:left" | Life
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | +9%
|-
| style="text-align:left" | Health
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | +5%
|}
</div>
=== Diversified franchise, well positioned in an attractive industry ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Life
| style="text-align:right" | 33%
|-
| style="text-align:left" | Health
| style="text-align:right" | 17%
|-
| style="text-align:left" | Large & Specialty
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|}
</div>
=== Laying the foundation for the next plan ===
* (
* (
* (
* (
* Confidence in sustaining earnings growth <sup>p. 8</sup>
* Guillaume Borie <sup>p. 9</sup>
* Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>
* FY25 Business Performance <sup>p. 9</sup>
== Strong delivery across our businesses ==
Line 104 ⟶ 142:
=== Strong delivery across our businesses ===
* '''France''' (27% of total GWP¹): <sup>p. 10</sup>
**
** '''Underlying earnings''' +7% to EUR 2.2bn <sup>p. 10</sup>
* '''Europe''' (38% of total GWP¹): <sup>p. 10</sup>
** '''Gross written premiums''' +6% to EUR 43bn <sup>p. 10</sup>
** '''Underlying earnings''' +9% to EUR 3.5bn <sup>p. 10</sup>
* '''AXA XL''' (17% of total GWP¹): <sup>p. 10</sup>
** '''Gross written premiums''' +4% to EUR 19bn <sup>p. 10</sup>
** '''Underlying earnings''' +9% to EUR 1.9bn <sup>p. 10</sup>
** '''Gross written premiums''' +13% to EUR 20bn <sup>p. 10</sup>
** '''Underlying earnings''' +6% to EUR 1.5bn <sup>p. 10</sup>
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 10</sup>.
* ¹ FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
=== P&C | Strong margins, confidence in sustaining growth ===
Line 135 ⟶ 161:
* '''Underlying earnings''' +9% to EUR 5.9bn (change FY25 vs. FY24 at constant FX) <sup>p. 11</sup>
* (donut) '''GWP''' EUR 58bn <sup>p. 11</sup>
** '''Retail''': 34% <sup>p. 11</sup>
** '''SME & Mid-market''': 33% <sup>p. 11</sup>
** '''AXA XL''' (Large & Specialty): 33% (includes AXA XL Re premiums of EUR 2.6bn) <sup>p. 11</sup>
* (diagram) '''2025 Strategic
** '''
** '''
* (diagram) '''Additional Strategic Initiatives''' <sup>p. 11</sup>
**
=== L&H | Good momentum, well positioned to capture growth opportunities ===
Line 154 ⟶ 179:
* '''Underlying earnings''' +7% to EUR 3.5bn (change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>
* (donut) '''GWP''' EUR 57bn <sup>p. 12</sup>
** '''Short-term''': 28% <sup>p. 12</sup>
** '''Long-term''': 72% <sup>p. 12</sup>
* (diagram) '''2025 Strategic
** '''
** '''Long-term business''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>
* (diagram) '''Additional Strategic Initiatives''' <sup>p. 12</sup>
**
* '''FY25 Financial Performance''' <sup>p. 13</sup>
* Alban de Mailly Nesle
* Group CFO <sup>p. 13</sup>
=== P&C | Continued disciplined growth ===
* (stacked bar) '''GWP & Other Revenues''' <sup>p. 14</sup>
** '''FY24 Total''': EUR 56.5bn <sup>p. 14</sup>
*** Commercial lines: EUR 35.8bn <sup>p. 14</sup>
*** AXA XL Reinsurance: EUR 2.6bn <sup>p. 14</sup>
*** Retail lines: EUR 18.1bn <sup>p. 14</sup>
** '''FY25 Total''': EUR 58.0bn <sup>p. 14</sup>
*** Commercial lines: EUR 35.8bn <sup>p. 14</sup>
*** AXA XL Reinsurance: EUR 2.6bn <sup>p. 14</sup>
*** Retail lines: EUR 19.7bn <sup>p. 14</sup>
*
** Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>
* '''AXA XL Reinsurance''': +8% change (o/w pricing +0.3%, o/w volume +7%) <sup>p. 14</sup>
** Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>
** Growth supported by alternative capital <sup>p. 14</sup>
* '''Retail lines''': +7% change (o/w pricing +5%, o/w volume +2%) <sup>p. 14</sup>
** Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) <sup>p. 14</sup>
* Change at constant scope and FX <sup>p. 14</sup>
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio breakdown <sup>p. 15</sup>
!
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Prior year reserve development
| style="text-align:right" | -1.6%
| style="text-align:right" | -1.1%
|-
| style="text-align:left" | Discount
| style="text-align:right" | -3.6%
| style="text-align:right" | -3.5%
|-
| style="text-align:left" | '''Total Combined Ratio'''
| style="text-align:right" | '''91.0%'''
| style="text-align:right" | '''90.6%'''
|}
</div>
=== P&C | Earnings growth from higher underwriting and financial result ===
*
* (waterfall) '''Underlying Earnings''' FY24 to FY25:
** FY24: EUR 5,510m <sup>p. 16</sup>
** '''Volume growth''': +EUR 292m <sup>p. 16</sup>
** '''Margin improvement''': +EUR 189m <sup>p. 16</sup>
Line 245 ⟶ 262:
** '''Tax''': -EUR 169m <sup>p. 16</sup>
** '''Affiliates, FX & other''': -EUR 150m <sup>p. 16</sup>
** FY25: EUR 5,872m <sup>p. 16</sup>
* '''Better underwriting result''' from strong volume growth and improved all-year combined ratio while enhancing reserve prudence <sup>p. 16</sup>
* '''Increase in investment income''' reflecting higher volumes and better reinvestment yields on fixed income assets <sup>p. 16</sup>
Line 252 ⟶ 270:
=== Life & Health | Strong growth in premiums, positive net flows ===
* (
**
*** '''
*** '''
*** '''
*
**
*** '''
*
*** '''Capital light G/A''': EUR 6.1bn (+7%) <sup>p. 17</sup>
*** '''Traditional G/A''': EUR 1.9bn (-7%) <sup>p. 17</sup>
* (bar) '''Health GWP & Other Revenues''' +5% (change at constant scope and FX) <sup>p. 17</sup>
** FY24 Total: EUR 17.5bn <sup>p. 17</sup>
*** '''Individual''': EUR 10.5bn <sup>p. 17</sup>
*** '''Group''': EUR 7.0bn <sup>p. 17</sup>
** FY25 Total: EUR 19.0bn <sup>p. 17</sup>
*** '''Individual''': EUR 11.1bn (+6%) <sup>p. 17</sup>
*** '''Group''': EUR 7.9bn (+4%) <sup>p. 17</sup>
* (bar) '''Net flows''': EUR +5.4bn vs. EUR +1.5bn in FY24 <sup>p. 17</sup>
** '''Protection''': +EUR 4.9bn <sup>p. 17</sup>
** '''Health''': +EUR 2.7bn <sup>p. 17</sup>
Line 266 ⟶ 294:
** '''Capital light G/A''': +EUR 1.2bn <sup>p. 17</sup>
** '''Traditional G/A''': -EUR 5.0bn <sup>p. 17</sup>
* '''Employee Benefits''' (
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
<div style="overflow-x:auto">
{| class="wikitable"
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | FY24 Total
! class="col-s" style="text-align:right" | FY25 Total
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left; font-weight:bold" | Total
| class="col-s" style="text-align:right; font-weight:bold" | EUR 50.9bn
| class="col-s" style="text-align:right; font-weight:bold" | EUR 49.4bn
| class="col-s" style="text-align:right; font-weight:bold" | -2%
|-
| style="text-align:left" | Protection & Health
| class="col-s" style="text-align:right" | EUR 39.4bn
| class="col-s" style="text-align:right" | EUR 31.4bn
| class="col-s" style="text-align:right" | -4%
|-
| style="text-align:left" | Unit-Linked
| class="col-s" style="text-align:right" | EUR 8.5bn
| class="col-s" style="text-align:right" | EUR 8.5bn
| class="col-s" style="text-align:right" | +18%
|-
| style="text-align:left" | Capital-light G/A
| class="col-s" style="text-align:right" | EUR 2.0bn
| class="col-s" style="text-align:right" | EUR 7.8bn
| class="col-s" style="text-align:right" | -10%
|-
| style="text-align:left" | Traditional G/A
| class="col-s" style="text-align:right" | EUR 1.0bn
| class="col-s" style="text-align:right" | EUR 1.7bn
| class="col-s" style="text-align:right" | -10%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable"
|+ NB CSM and NBV, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | Metric
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | NB CSM (pre-tax)
| class="col-s" style="text-align:right" | EUR 2.2bn
| class="col-s" style="text-align:right" | EUR 2.2bn
| class="col-s" style="text-align:right" | +3%
|-
| style="text-align:left" | NBV (post-tax)
| class="col-s" style="text-align:right" | EUR 2.3bn
| class="col-s" style="text-align:right" | EUR 2.2bn
| class="col-s" style="text-align:right" | stable
|-
| style="text-align:left" | NBV margin
| class="col-s" style="text-align:right" | 4.4%
| class="col-s" style="text-align:right" | 4.5%
| class="col-s" style="text-align:right" | —
|}
</div>
=== Life & Health | Growth in new business driving Normalized CSM growth ===
* '''Normalized CSM''' up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates (change at constant scope and FX) <sup>p. 19</sup>
* (waterfall) '''Contractual Service Margin rollforward''':
** FY24: EUR 33.6bn <sup>p. 19</sup>
** '''New business CSM''': +EUR 2.2bn <sup>p. 19</sup>
** '''Underlying return on in-force''': +EUR 1.3bn <sup>p. 19</sup>
Line 291 ⟶ 369:
** '''Operating variance''': -EUR 0.3bn <sup>p. 19</sup>
** '''Affiliates, FX & other''': -EUR 1.4bn <sup>p. 19</sup>
** FY25: EUR 33.0bn <sup>p. 19</sup>
* '''Economic variance''' reflecting government spreads tightening and positive equity market returns <sup>p. 19</sup>
* '''Operating variance''' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>
* '''FX impact''' mainly from JPY and HKD depreciation <sup>p. 19</sup>
* '''CSM o/w Life''': FY24 EUR 25.8bn, FY25 EUR 25.4bn <sup>p. 19</sup>
=== Life & Health | Strong momentum in both short-term and long-term business ===
*
* (waterfall) '''Underlying Earnings''' FY24 to FY25:
** FY24: EUR 3,323m <sup>p. 20</sup>
** '''Short-term technical margin''': +EUR 60m <sup>p. 20</sup>
** '''Long-term result incl. CSM release''': +EUR 156m <sup>p. 20</sup>
** '''Financial result''': -EUR 11m <sup>p. 20</sup>
** '''Tax, FX and others''': -EUR 27m <sup>p. 20</sup>
** FY25: EUR 3,501m <sup>p. 20</sup>
*** '''Short-term technical margin''': EUR 479m <sup>p. 20</sup>
*** '''Long-term result incl. CSM release''': EUR 2,804m <sup>p. 20</sup>
*** '''Financial result''': EUR 946m <sup>p. 20</sup>
*** '''Tax & others''': -EUR 728m <sup>p. 20</sup>
* '''Strong short-term technical margin''' reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn) <sup>p. 20</sup>
* '''Higher long-term results''' from increase in CSM release (+8%) reflecting growth in reserve base, including from favorable equity market performance, and better margins <sup>p. 20</sup>
* '''Underlying Earnings
== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ==
Line 321 ⟶ 399:
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
* '''Underlying earnings''' (constant FX) +6% to EUR 8.4bn (FY25) from EUR 8.1bn (FY24) <sup>p. 21</sup>
** '''Property & Casualty''': EUR 5.9bn (
** '''Life & Health''': EUR 3.5bn (
** '''Asset Management''': EUR 0.2bn (
** '''Holdings & other''':
* '''Net income''' (reported) +26% to EUR 9.8bn (
**
*
**
**
** +3% from capital management <sup>p. 21</sup>
** -2% from forex <sup>p. 21</sup>
*** Including -1% from temporary earnings dilution from AXA IM sale due to timing of anti-dilutive share buyback <sup>p. 21</sup>
* '''Underlying earnings'''
* '''Holding cost'''
* '''Net income'''
* '''Financial flows'''
* '''Shareholders' equity''' (Group share) <sup>p. 22</sup>
** '''SHE (excl. OCI)''': EUR 54.0bn (FY25) vs EUR 52.7bn (HY25) vs EUR 58.0bn (FY24) <sup>p. 22</sup>
** '''Net OCI''': EUR -6.8bn (FY25) vs EUR -7.2bn (HY25) vs EUR -8.1bn (FY24) <sup>p. 22</sup>
** '''SHE (excl. OCI & undated subordinated debt)''': EUR 49.4bn (FY25) vs EUR 47.0bn (HY25) vs EUR 53.2bn (FY24) <sup>p. 22</sup>
** '''Debt gearing''': 22.3% (FY25) vs 23.4% (HY25) vs 20.6% (FY24) <sup>p. 22</sup>
** '''Underlying ROE''': 16.0% (FY25) vs 17.5% (HY25) vs 15.2% (FY24) <sup>p. 22</sup>
* '''Opening Shareholders' equity''': EUR 49.9bn (FY24 to FY25) and EUR 45.5bn (HY25 to FY25) <sup>p. 22</sup>
* '''Change in Net OCI''': EUR 1.3bn (FY24 to FY25) and EUR 0.4bn (HY25 to FY25) <sup>p. 22</sup>
* '''Net income for the period''': EUR 9.8bn (FY24 to FY25) and EUR 5.9bn (HY25 to FY25) <sup>p. 22</sup>
* '''Dividend''': EUR -4.6bn (FY24 to FY25) <sup>p. 22</sup>
* '''Annual share buyback''': EUR -1.2bn (FY24 to FY25) <sup>p. 22</sup>
* '''Anti-dilutive share buyback following the sale of AXA IM''': EUR -3.5bn (FY24 to FY25) and EUR -3.5bn (HY25 to FY25) <sup>p. 22</sup>
* '''Undated subordinated debt''' (including interest charges): EUR -0.3bn (FY24 to FY25) and EUR -1.2bn (HY25 to FY25) <sup>p. 22</sup>
* '''Forex''': EUR -3.5bn (FY24 to FY25) and EUR -0.1bn (HY25 to FY25) <sup>p. 22</sup>
* '''Other''': EUR -0.6bn (FY24 to FY25) and EUR 0.3bn (HY25 to FY25) <sup>p. 22</sup>
* '''Closing Shareholders' equity''': EUR 47.2bn (FY24 to FY25) and EUR 47.2bn (HY25 to FY25) <sup>p. 22</sup>
== Higher organic cash remittance and robust cash position at Holding ==
Line 451 ⟶ 439:
=== Higher organic cash remittance and robust cash position at Holding ===
* (bar) '''Net Cash Remittance''': EUR 7.5bn (
** FY24 breakdown:
*
*
*
* '''Annual share buyback''': -EUR 1.2bn <sup>p. 23</sup>
* '''Anti-dilutive share buyback following the sale of AXA IM''': -EUR 3.5bn <sup>p. 23</sup>
* '''Holding costs and interest expenses''': -EUR 1.3bn <sup>p. 23</sup>
* '''Change in net debt''': +EUR 1.6bn <sup>p. 23</sup>
* '''M&A and other''': +EUR 3.1bn <sup>p. 23</sup>
* '''FY25 Cash position''': EUR 5.6bn <sup>p. 23</sup>
* ¹Based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>.
* ²EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>.
== Solvency II at 224% ==
Line 498 ⟶ 458:
=== Solvency II at 224% ===
* (waterfall) '''
** Changes: +EUR 0.2bn, +EUR 8.8bn, -EUR 0.4bn, -EUR 2.1bn, -EUR 6.0bn (Foreseeable dividends: EUR 4.8bn; Provision for annual Share buyback for 2026: EUR -1.25bn), -EUR 0.1bn <sup>p. 24</sup>
**
**
** '''Normalized capital generation''': +28pts <sup>p. 24</sup>
**
**
*
**
* (bar) '''Key sensitivities''' on Ratio as of December 31, 2025 (224%) <sup>p. 24</sup>
** '''Interest rate +50bps''': +2 pts <sup>p. 24</sup>
** '''Interest rate -50bps''': -1 pt <sup>p. 24</sup>
** '''Corporate spreads +50bps''': -1 pt <sup>p. 24</sup>
** '''Euro Sovereign spreads +50bps¹''': -7 pts <sup>p. 24</sup>
** '''Credit migration²''': -4 pts <sup>p. 24</sup>
** '''Listed Equity (excl. PE & Infra) +25%''': -1 pt <sup>p. 24</sup>
** '''Listed Equity (excl. PE & Infra) -25%''': +2 pts <sup>p. 24</sup>
** '''PE & Infra +25%''': +14 pts <sup>p. 24</sup>
** '''PE & Infra -25%''': -19 pts <sup>p. 24</sup>
** '''Inflation swap curve +50bps''': -5 pts <sup>p. 24</sup>
* ¹
* ²
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
Line 535 ⟶ 491:
** No change expected in organic capital generation <sup>p. 25</sup>
** Additional capital flexibility <sup>p. 25</sup>
* ¹
== Thomas Buberl, Group CEO conclusion ==
Line 547 ⟶ 503:
=== Conclusion ===
* '''Record results''', at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>
* All businesses in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>
* '''Diversified franchise''', well-positioned to capture future growth opportunities <sup>p. 27</sup>
* Laying foundations for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>
Line 556 ⟶ 512:
=== February 26, 2026 Q&A Full Year 2025 earnings ===
* Q&A for Full Year 2025 Earnings
* Date: February 26, 2026 <sup>p. 28</sup>
=== AXA Investor Relations | Keep in touch ===
* '''
**
**
** June 2: BNP Paribas Exane CEO Conference in Paris <sup>p. 29</sup>
** June 2-4: Goldman Sachs European Financials Conference in Zurich <sup>p. 29</sup>
** July 31: HY26 Earnings Release in Paris <sup>p. 29</sup>
* '''Contact us''' <sup>p. 29</sup>
** Investor Relations: +33 1 40 75 48 42 <sup>p. 29</sup>
** Email: investor.relations@axa.com <sup>p. 29</sup>
* '''Follow us''' <sup>p. 29</sup>
** Website: www.axa.com <sup>p. 29</sup>
** Social media icons for YouTube, Facebook, Instagram, Twitter, LinkedIn, and a leaf icon <sup>p. 29</sup>
== Appendices ==
Line 602 ⟶ 537:
* Appendices <sup>p. 30</sup>
*
* Additional P&C disclosures p.36
* Additional IFRS17 disclosures p.41
* Sustainability p.44
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
Line 611 ⟶ 548:
** '''FY25''': Total EUR 22.3bn; Tier 1 EUR 3.5bn, Tier 2 EUR 12.2bn, Senior debt EUR 4.6bn <sup>p. 32</sup>
** '''Jan 1st 2026''' (End of the grandfathering period): Total EUR 20.3bn; Tier 1 EUR 5.8bn (o/w EUR 0.4bn redeemed in Jan 2026), Tier 2 EUR 11.3bn, Senior debt EUR 3.2bn <sup>p. 32</sup>
* '''Debt gearing''': 20.6% for FY24
* (stacked bar) '''Contractual maturity breakdown''' (EUR bn):
** '''2025''': Senior debt 0.5, Tier 2 0.5, Tier 1 0.5 <sup>p. 32</sup>
** '''2026''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
** '''2028''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
** '''2029''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
** '''2030''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
** '''2031-2039''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
** '''≥2040''': Senior debt 10.8, Tier 2 0.2, Tier 1 1.4 <sup>p. 32</sup>
** '''Undated''': Senior debt 4.6, Tier 2 0.7, Tier 1 0.5 <sup>p. 32</sup>
* '''o/w Grandfathered debt''' (Contractual maturity, EUR bn):
** '''2031-2039''': Tier 1 0.7, Tier 2 0.2 <sup>p. 32</sup>
** '''≥2040''': Tier 1 0.2 <sup>p. 32</sup>
** '''Undated''': Tier 1 0.5 <sup>p. 32</sup>
* (stacked bar) '''Economic maturity breakdown''' (EUR bn):
** '''2025''': Senior debt 0.1, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
** '''2026''': Senior debt 0.1, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
** '''2028''': Senior debt 2.0, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
** '''2029''': Senior debt 0.9, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
** '''2030''': Senior debt 0.7, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
** '''2031-2039''': Senior debt 6.4, Tier 2 0.2, Tier 1 1.5 <sup>p. 32</sup>
** '''≥2040''': Senior debt 0.5, Tier 2 0.1, Tier 1 0.7 <sup>p. 32</sup>
** '''Undated''': Senior debt 4.0, Tier 2 0.1, Tier 1 0.7 <sup>p. 32</sup>
* '''o/w Grandfathered debt''' (Economic maturity, EUR bn):
** '''2031-2039''': Tier 1 0.7, Tier 2 0.2 <sup>p. 32</sup>
** '''≥2040''': Tier 1 0.2 <sup>p. 32</sup>
** '''Undated''': Tier 1 0.8 <sup>p. 32</sup>
* Nominal debt <sup>p. 32</sup>
* In January 2026, AXA has called (i) the remaining T2 GF GBP 139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF EUR 250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup>
* Economic maturity takes into account the first date of step up calls on institutionally placed subordinated debt <sup>p. 32</sup>
* For Solvency 2 RT1 debt, which has no step-up, the undated nature of the instrument is retained for the purpose of this diagram <sup>p. 32</sup>
* This should not be construed, nor relied upon, as an indication that the instrument will not be called for redemption when callable <sup>p. 32</sup>
* Such decision will depend on several factors, including capital and liquidity position and refinancing economics at the prevailing time <sup>p. 32</sup>
=== General Account invested assets ===
Line 828 ⟶ 594:
** '''Cash''': 4% <sup>p. 33</sup>
** '''Policy loans''': 0% <sup>p. 33</sup>
* '''Invested assets''' (100%) in EUR bn (FY25):
** '''Fixed income''': EUR 345bn (77%) <sup>p. 33</sup>
*** o/w '''Government bonds''': EUR 167bn (37%) <sup>p. 33</sup>
*** o/w '''Corporate bonds and loans''': EUR 121bn (27%) <sup>p. 33</sup>
*** o/w '''Other fixed income'''¹: EUR 56bn (13%) <sup>p. 33</sup>
** '''Real estate''': EUR 41bn (9%) <sup>p. 33</sup>
** '''Infrastructure equity''': EUR 10bn (2%) <sup>p. 33</sup>
** '''Listed equities'''²: EUR 10bn (2%) <sup>p. 33</sup>
** '''Private equity and hedge funds'''³: EUR 23bn (5%) <sup>p. 33</sup>
** '''Cash''': EUR 19bn (4%) <sup>p. 33</sup>
** '''Policy loans''': EUR 2bn (0%) <sup>p. 33</sup>
** '''Total Insurance Invested Assets'''⁴: EUR 450bn (100%) <sup>p. 33</sup>
* '''Duration gap''': -0.4 year <sup>p. 33</sup>
* ¹ '''Other fixed income''' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn) and Agency Pools (EUR 8bn) <sup>p. 33</sup>
* ² '''Listed equities''' includes hedges;
* ³ '''Private equity and hedge funds''' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn) and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>
* ⁴
=== Structured and Private Credit assets ===
* '''Invested assets''' (100%) in EUR bn (FY25):
** '''Residential Mortgages''': EUR 16bn (4% of G/A portfolio) <sup>p. 34</sup>
*** EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 34</sup>
** '''CLO & ABS''': EUR 25bn (6% of G/A portfolio) <sup>p. 34</sup>
*** 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) <sup>p. 34</sup>
** '''Infrastructure debt''': EUR 8bn (2% of G/A portfolio) <sup>p. 34</sup>
*** Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 34</sup>
** '''CRE debt''': EUR 8bn (2% of G/A portfolio) <sup>p. 34</sup>
*** Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 34</sup>
** '''Mid-Market lending''': EUR 10bn (2% of G/A portfolio) <sup>p. 34</sup>
*** Strong diversification with EUR 8m average ticket <sup>p. 34</sup>
*** Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 34</sup>
** '''Other''': EUR 2bn (0% of G/A portfolio) <sup>p. 34</sup>
** '''Total Structured and Private Credit Assets''': EUR 69bn (15% of G/A portfolio) <sup>p. 34</sup>
*** o/w 54% participating <sup>p. 34</sup>
* G/A: General Account <sup>p. 34</sup>
=== Investment portfolio | Fixed Income reinvestment ===
* (donut) '''FY25 Fixed Income Reinvestment''': EUR 57bn <sup>p. 35</sup>
** '''Government bonds & related'''
** '''Investment grade credit''': 40% (Average rating: A) <sup>p. 35</sup>
** '''ABS/CLO/IG fund financing''': 21% <sup>p. 35</sup>
** '''Below investment grade credit''': 7% <sup>p. 35</sup>
* (bar) '''FY25 Fixed Income Reinvestment Yield''':
** '''Public fixed income'''
** '''Private & Structured fixed income'''
** '''Total fixed income''': 3.9% <sup>p. 35</sup>
*
** Average duration of 9 years <sup>p. 35</sup>
** Includes EUR 19.7bn of
** Gradual shift from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
* ¹ '''Government
* ² '''Private & Structured
* '''Table of contents''':
**
** 2. Additional P&C disclosures, p.36 <sup>p. 36</sup>
** 3. Additional IFRS17 disclosures, p.41 <sup>p. 36</sup>
** 4. Sustainability, p.44 <sup>p. 36</sup>
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 969 ⟶ 669:
*** UK & Lloyds: 19% <sup>p. 37</sup>
* Leading market positions across lines <sup>p. 37</sup>
** Top 3 globally
***
***
*** Fine Art & Specie (Source: Industry Research Biz (January 2026)) <sup>p. 37</sup>
* Managing the cycle to deliver consistent profitability <sup>p. 37</sup>
** (scatter plot) '''Profitability vs. Ex-price growth''':
*** Property (top right) <sup>p. 37</sup>
*** Specialty (middle right) <sup>p. 37</sup>
*** Casualty (middle left) <sup>p. 37</sup>
*** Professional lines (bottom left) <sup>p. 37</sup>
=== P&C | Focus on Reserves ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Year
! class="col-s" style="text-align:right" | IFRS4
! class="col-s" style="text-align:right" | IFRS17
|-
| style="text-align:left" | FY18
| style="text-align:right" | 179%
| style="text-align:right" | —
|-
| style="text-align:left" | FY19
| style="text-align:right" | 185%
| style="text-align:right" | —
|-
| style="text-align:left" | FY20
| style="text-align:right" | 193%
| style="text-align:right" | —
|-
| style="text-align:left" | FY21
| style="text-align:right" | 188%
| style="text-align:right" | —
|-
| style="text-align:left" | FY22
| style="text-align:right" | 189%
| style="text-align:right" | 198%
|-
| style="text-align:left" | FY23
| style="text-align:right" | —
| style="text-align:right" | 195%
|-
| style="text-align:left" | FY24
| style="text-align:right" | —
| style="text-align:right" | 180%
|-
| style="text-align:left" | FY25
| style="text-align:right" | —
| style="text-align:right" | 175%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Technical reserves ratio (Net undiscounted technical reserves /Net earned premiums) <sup>p. 38</sup>
! style="text-align:left" | Year
! class="col-s" style="text-align:right" | IFRS4
! class="col-s" style="text-align:right" | IFRS17
|-
| style="text-align:left" | FY18
| style="text-align:right" | 213%
| style="text-align:right" | —
|-
| style="text-align:left" | FY19
| style="text-align:right" | 227%
| style="text-align:right" | —
|-
| style="text-align:left" | FY20
| style="text-align:right" | 233%
| style="text-align:right" | —
|-
| style="text-align:left" | FY21
| style="text-align:right" | 226%
| style="text-align:right" | —
|-
| style="text-align:left" | FY22
| style="text-align:right" | 227%
| style="text-align:right" | 234%
|-
| style="text-align:left" | FY23
| style="text-align:right" | —
| style="text-align:right" | 232%
|-
| style="text-align:left" | FY24
| style="text-align:right" | —
| style="text-align:right" | 216%
|-
| style="text-align:left" | FY25
| style="text-align:right" | —
| style="text-align:right" | 210%
|}
</div>
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 ===
* Stable retention levels maintained in 2026 as in 2025 <sup>p. 39</sup>
* (bar
** '''EU Windstorm''': Capacity EUR 4.0bn, Retention EUR 600m <sup>p. 39</sup>
** '''Europe Flood''': Capacity EUR 2.1bn, Retention EUR 450m <sup>p. 39</sup>
Line 995 ⟶ 774:
** '''NA Earthquake''': Capacity EUR 1.2bn, Retention EUR 600m <sup>p. 39</sup>
** '''Per other perils''': Capacity [unclear, visually around EUR 0.8bn], Retention EUR 400m <sup>p. 39</sup>
*** Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils <sup>p. 39</sup>
***
* (diagram) '''Reinsurance segment (illustrative)''': Alternative Capital & Cat Bonds <sup>p. 39</sup>
* Excludes local reinsurance covers <sup>p. 39</sup>
* Varying retention between MX and NA (EUR 400m MX, EUR 600m NA) <sup>p. 39</sup>
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
*
** (bar) '''More severe years - Negative deviation in ca. 40% of cases
*** 1/20y (95th percentile): -EUR 1.2bn <sup>p. 40</sup>
*** 1/10y (90th percentile): -EUR 0.8bn <sup>p. 40</sup>
*** 1/5y (80th percentile): -EUR 0.4bn <sup>p. 40</sup>
** (bar) '''Median (50th percentile)''': EUR 0.1bn <sup>p. 40</sup>
** (bar) '''Less severe years - Positive deviation in ca. 60% of cases
*** 1/5y (20th percentile): EUR 0.5bn <sup>p. 40</sup>
*** 1/10y (10th percentile): EUR 0.7bn <sup>p. 40</sup>
*** 1/20y (5th percentile): EUR 0.8bn <sup>p. 40</sup>
*
** (bar) '''2025''': EUR 2.6bn
** (bar) '''2026''': EUR 2.7bn
* Natural catastrophe cost
* Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance) <sup>p. 40</sup>
*
*
*
*
=== P&C | Margin analysis ===
* (flow) '''
** '''
*** '''
*** '''
*** '''
** '''Current Accident Year
*** '''
*** '''Current Accident Year Net Claims reserves''': EUR 19.0bn <sup>p. 42</sup>
*** '''Duration''': 4.0 years <sup>p. 42</sup>
*** '''Current Accident Year Discount Rate''': 2.8% <sup>p. 42</sup>
** '''Prior Years' Reserve Development (PYD)'''
*** '''PYD ratio''': -1.1%
** '''Sensitivity to Current Accident Year discount rate changes''' <sup>p. 42</sup>
*** +25bps: +EUR 0.2bn <sup>p. 42</sup>
*** -25bps: -EUR 0.2bn <sup>p. 42</sup>
* (flow) '''Financial Result''' (
** '''Investment Income'''
*** '''FY25 Average Assets''': EUR 115bn <sup>p. 42</sup>
*** '''Asset book yield''': 3.5% <sup>p. 42</sup>
*** '''FY25 Reinvestment yield¹'''
** '''Insurance Finance Expenses'''
*** '''FY24 Reserves at locked-in rate''': EUR 71bn <sup>p. 42</sup>
*** '''Liability book yield''': 1.9% <sup>p. 42</sup>
** '''2025 Insurance Finance Expenses''' (pre-tax)
** '''Sensitivity of 2025e Insurance Finance Expenses to changes in 2025 current AY Discount''' <sup>p. 42</sup>
*** +25bps: ~EUR -50m <sup>p. 42</sup>
*** -25bps: ~EUR +50m <sup>p. 42</sup>
* (flow) '''Underlying Earnings before tax''': EUR 8,040 (change: +EUR 681) <sup>p. 42</sup>
**
**
** '''Underlying Earnings''': EUR 5,872 (change: +EUR 501) <sup>p. 42</sup>
*** '''Growth vs. FY24''' (at constant FX): +9% <sup>p. 42</sup>
=== L&H | Margin analysis ===
* Includes scope impact <sup>p. 43</sup>
* (flow) '''
** '''
***
*** '''
*** '''
** '''
*** '''
*** '''
*** '''Baseline''': 33.3 <sup>p. 43</sup>
*** '''Interest rates
*** '''Interest rates
*** '''Sovereign spreads
*** '''Sovereign spreads
*** '''Corporate spread
*** '''Corporate spread
*** '''Equities''' +25%
*** '''Equities''' -25%
* (flow) '''Financial Result''' (
** '''Investment Income''' (non-VFA only)
*** '''FY25 Average Assets''': EUR 98bn <sup>p. 43</sup>
*** '''Asset book yield''': 2.5% <sup>p. 43</sup>
*** '''FY25 Reinvestment yield¹'''
** '''Insurance Finance Expenses''' (non-VFA only)
*** '''FY24 Reserves at locked-in rate''': EUR 62bn <sup>p. 43</sup>
*** '''Liability book yield''': 2.5% <sup>p. 43</sup>
* (flow) '''Underlying Earnings before tax''': EUR 4,229 (change: +EUR 205) <sup>p. 43</sup>
**
**
** '''Underlying Earnings''': EUR 3,501 (change: +EUR 219) <sup>p. 43</sup>
*** '''Growth vs. FY24''' (at constant FX): +7% <sup>p. 43</sup>
* '''Invested assets''' (100%) (in EUR billion) <sup>p. 43</sup>
** '''Residential Mortgages''': EUR 16 (4% of total G/A portfolio) <sup>p. 43</sup>
*** EUR 6bn Dutch mortgages, NHG guaranteed <sup>p. 43</sup>
*** EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 43</sup>
** '''CLO & ABS''': EUR 25 (6% of total G/A portfolio) <sup>p. 43</sup>
*** 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) <sup>p. 43</sup>
** '''Infrastructure debt''': EUR 8 (2% of total G/A portfolio) <sup>p. 43</sup>
*** Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 43</sup>
** '''CRE debt''': EUR 8 (2% of total G/A portfolio) <sup>p. 43</sup>
*** Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 43</sup>
** '''Mid-Market lending''': EUR 10 (2% of total G/A portfolio) <sup>p. 43</sup>
*** Strong diversification with EUR 8m average ticket <sup>p. 43</sup>
*** Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 43</sup>
** '''Other''': EUR 2 (0% of total G/A portfolio) <sup>p. 43</sup>
** '''Total Structured and Private Credit Assets''': EUR 69 (15% of total G/A portfolio) <sup>p. 43</sup>
*** o/w 54% participating <sup>p. 43</sup>
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
Line 1,157 ⟶ 899:
** '''Target''': EUR 6bn³ in P&C GWP to support transition underwriting (cumulative 2024-2026) <sup>p. 45</sup>
** '''2025 Result''': EUR 4.6bn <sup>p. 45</sup>
** '''Target''': >20,000⁴ climate adaptation solutions & services (cumulative 2024-2026)
*** Target revised in 2025 <sup>p. 45</sup>
** '''2025 Result''': 19,698 Cumulative 2024-2025 <sup>p. 45</sup>
** '''Target''': >20m⁵ inclusive insurance customers by 2026 <sup>p. 45</sup>
Line 1,168 ⟶ 911:
** '''Target''': 50% Percentage of AXA Group employees engaged in volunteering activities by 2026 <sup>p. 45</sup>
** '''2025 Result''': 56% <sup>p. 45</sup>
* Footnote 7: Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030. <sup>p. 45</sup>
* Footnote 8: Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage). <sup>p. 45</sup>
=== Sustainability Performance & Ratings ===
* '''S&P Global'''
** '''2025 percentile''': 97th in Dow Jones Best-in-Class Europe & World indices <sup>p. 46</sup>
** '''2025 score''': AAA <sup>p. 46</sup>
* '''
** '''2025 score''': AAA <sup>p. 46</sup>
* '''CDP'''
** '''2025 score''': B <sup>p. 46</sup>
* '''Morningstar Sustainalytics'''
** '''2025 ESG Risk Rating''': 17.0 - Low risk <sup>p. 46</sup>
* '''FTSE Russell'''
** '''2025 score''': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
* The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares) <sup>p. 46</sup>.
Line 1,199 ⟶ 936:
* '''AXA XL''': includes insurance and reinsurance activities and holding <sup>p. 47</sup>.
* '''Asia, Africa & EME-LATAM''': <sup>p. 47</sup>
** '''Asia''': Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated <sup>p. 47</sup>.
** China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings and net income <sup>p. 47</sup>.
** '''Africa''': Morocco (insurance activities and holding) and Nigeria (insurance activities and holding), Egypt (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>.
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding) and Türkiye (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>.
** Russia (Reso) (insurance activities)
** AXA Mediterranean Holdings <sup>p. 47</sup>.
* '''Transversal & Other''': includes AXA Assistance, AXA Liabilities Managers, AXA and other Central Holdings <sup>p. 47</sup>.
* '''AXA Investment Managers (until July 1, 2025)''': includes AXA Investment Managers, Select (previously referred to as Architas) and Capza which are fully consolidated and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>.
* Unless otherwise specified, all comparative figures for going back to 2023 are under the IFRS17/9 accounting standards
* Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4, the applicable accounting standard that preceded the implementation of IFRS17/9 <sup>p. 47</sup>.
=== Glossary ===
Line 1,218 ⟶ 955:
* '''Financial result''': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup>.
* '''Gross Written Premiums and Other Revenues (GWP & Other Revenues)''': represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business) <sup>p. 48</sup>.
* '''New Business Value (NBV)''': the value of newly issued contracts during the current year <sup>p. 48</sup>.
** It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>.
* '''New Business Contractual Service Margin (NB CSM)''': a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>.
* '''New Business Value margin (NBV margin)''': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup>.
* '''Operating variance''': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes
** Operating variance is net of reinsurance <sup>p. 48</sup>.
* '''Present value of expected premiums (PVEP)''': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term <sup>p. 48</sup>.
** PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>.
* '''Technical experience''': consists the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup>.
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>.
Line 1,241 ⟶ 975:
== Abbreviations ==
* '''ABS''': Asset-Backed Securities
* '''AEP''': Aggregate Exceedance Probability
* '''AI''': Artificial Intelligence
* '''AMF''': Autorité des
* '''APAC''': Asia-Pacific
* '''AY''': Accident Year
Line 1,254 ⟶ 986:
* '''CSA''': Corporate Sustainability Assessment
* '''CSM''': Contractual Service Margin
* '''CY''':
* '''DPS''': Dividend Per Share
* '''EME''':
* '''EOF''': Eligible Own Funds
* '''EPS''': Earnings Per Share
Line 1,264 ⟶ 996:
* '''FX''': Foreign Exchange
* '''GAAP''': Generally Accepted Accounting Principles
* '''GEP''': Gross Earned
* '''GWP''': Gross Written Premiums
* '''HKD''': Hong Kong Dollar
Line 1,273 ⟶ 1,003:
* '''IFRS''': International Financial Reporting Standards
* '''IG''': Investment Grade
* '''
* '''LATAM''': Latin America
* '''LTV''': Loan-to-Value
* '''MSCI''': Morgan Stanley Capital International
Line 1,281 ⟶ 1,012:
* '''NBV''': New Business Value
* '''NHG''': Nationale Hypotheek Garantie
* '''OCI''': Other Comprehensive Income
* '''PAA''': Premium Allocation Approach
Line 1,287 ⟶ 1,017:
* '''PVEP''': Present Value of Expected Profits
* '''PYD''': Prior Years' Reserve Development
* '''RCG''':
* '''ROE''': Return On Equity
* '''SCR''': Solvency Capital Requirement
| |||